These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17690597)
1. Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. Montgomery SA; Kasper S Int Clin Psychopharmacol; 2007 Sep; 22(5):283-91. PubMed ID: 17690597 [TBL] [Abstract][Full Text] [Related]
2. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control. Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074 [TBL] [Abstract][Full Text] [Related]
4. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Agomelatine in Depressed Patients with Diabetes: A Systematic Review and Meta-Analysis. Gędek A; Modrzejewski S; Materna M; Szular Z; Wichniak A; Mierzejewski P; Dominiak M Int J Mol Sci; 2024 Nov; 25(23):. PubMed ID: 39684343 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
8. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials. Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials. Dunner DL; Lipschitz A; Pitts CD; Davies JT Clin Ther; 2005 Dec; 27(12):1901-11. PubMed ID: 16507376 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Pollok J; van Agteren JE; Carson-Chahhoud KV Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235 [TBL] [Abstract][Full Text] [Related]
11. Oral budesonide for induction of remission in ulcerative colitis. Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719 [TBL] [Abstract][Full Text] [Related]
13. Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo. Sampson E; Mills NT; Hori H; Cearns M; Schwarte K; Hohoff C; Oliver Schubert K; Fourrier C; Baune BT Brain Behav Immun; 2025 Jan; 123():43-56. PubMed ID: 39243988 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients. Perlemuter G; Cacoub P; Valla D; Guyader D; Saba B; Batailler C; Moore K CNS Drugs; 2016 Sep; 30(9):877-88. PubMed ID: 27342740 [TBL] [Abstract][Full Text] [Related]
15. The effect of sample site and collection procedure on identification of SARS-CoV-2 infection. Davenport C; Arevalo-Rodriguez I; Mateos-Haro M; Berhane S; Dinnes J; Spijker R; Buitrago-Garcia D; Ciapponi A; Takwoingi Y; Deeks JJ; Emperador D; Leeflang MMG; Van den Bruel A; Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014780. PubMed ID: 39679851 [TBL] [Abstract][Full Text] [Related]
16. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
18. A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder. Kato M; Shiosakai M; Kuwahara K; Iba K; Shimada Y; Saito M; Sekine D; Aoki K; Shiomi Y; Higuchi T CNS Drugs; 2024 Dec; 38(12):1003-1016. PubMed ID: 39424742 [TBL] [Abstract][Full Text] [Related]
19. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. Soares CN; Kornstein SG; Thase ME; Jiang Q; Guico-Pabia CJ J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of interpersonal psychotherapy in comparison to other psychological and pharmacological interventions for reducing depressive symptoms in women diagnosed with postpartum depression in low- and middle-income countries: A systematic review. Kang HK; Bisht B; Kaur M; Alexis O; Worsley A; John D Campbell Syst Rev; 2024 Jun; 20(2):e1399. PubMed ID: 38645302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]